Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Core Silver and Arcus Development Group Enter into a Binding Letter of Intent for a Business Combination Transaction and Sign a Definitive Option Agreement for the Touleary Project
-
Fenix Outdoor International to acquire outstanding minority in Devold
-
Q1 report Fenix Outdoor International AG
-
Inventus Announces Upsize of Non-Brokered Flow-Through Financing to $2.5 Million
-
Aeluma Appoints Willy Rachmady Vice President of Strategic Partnerships and Ecosystem
-
Eagle Plains Announces Letter of Intent with Pacific Bay Minerals for the Haskins Critical Minerals Project, British Columbia
-
TaxBandits Supports Filers Ahead of April 30 Form 941 Deadline, Marking First 941 Deadline With Protection Plus
-
Microbix Product Results Being Presented at 2026 PASCV
-
Ligand to Acquire XOMA Royalty, Further Accelerating Profit Growth and Strengthening Ligand’s Position as a Leading Biopharma Royalty Aggregator
-
Altimmune Announces Closing of $225 Million Oversubscribed Public Offering of Securities
-
Harrow To Report First Quarter 2026 Financial Results After Market Close on May 11, 2026
-
Intellia Therapeutics Reports Positive Phase 3 Results in Hereditary Angioedema, Marking a Global First for In Vivo Gene Editing
-
Martin Marietta Appoints Christopher W. Samborski Chief Operating Officer
-
Recognized for Best Use of Tech in HR, Vetty Wins Bronze Stevie® in 2026 American Business Awards®
-
Oruka Therapeutics Announces Positive Week 16 Data for ORKA-001 from the Ongoing EVERLAST-A Phase 2a Trial in Moderate-to-Severe Plaque Psoriasis
-
Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for First Quarter 2026
-
U.S. Energy Corp. Signs Five-Year Helium Offtake Agreement with Investment-Grade Global Leader in Industrial Gases
-
Ocular Therapeutix™ to Participate in May Scientific and Investor Conferences
-
Verizon’s Transformation Actions Deliver Growth & Profitability in 1Q26; Company Raises Adjusted EPS Guidance
-
Graphite One Provides FAST-41 Permitting Update For Graphite Creek Project
-
Monster Energy and Monster Army Riders Sweep Pro Men's Podium at Opening Stop of the 2026 Monster Army Recon Tour in San Diego
-
Intellia Therapeutics Initiates Rolling Submission of Biologics License Application to FDA for Lonvoguran Ziclumeran (lonvo-z) as a One-Time Treatment for Hereditary Angioedema
-
Alliance Resource Partners, L.P. Reports First Quarter Financial and Operating Results; Declares Quarterly Cash Distribution of $0.60 Per Unit; and Updates 2026 Guidance
-
Stop Guessing What Gen Next is Watching: Portrait TV Unveils Culture-First Streaming Slate Powered by AI Audience Intelligence
-
Statement from United Airlines CEO Scott Kirby
-
Ligand to Acquire XOMA Royalty, Further Accelerating Profit Growth and Strengthening Ligand’s Position as a Leading Biopharma Royalty Aggregator
-
Keeper Security Introduces Verify Mode and New Browser Controls to Prevent Phishing and Credential Misuse
-
First Farmers and Merchants Corporation Reports First Quarter Net Income up 22.4% to $5.5 Million
-
Joby Brings Electric Air Taxis to New York City in Week-Long Flight Campaign
-
Valmont Industries, Inc. to Participate in Gabelli’s Omaha Value Investor Conference
-
Solstice Advanced Materials Declares Dividend of $0.075 per Common Share
-
Real to Acquire REMAX, Creating a Leading Technology-Enabled Global Real Estate Platform
-
Sionna Therapeutics Completes Enrollment in PreciSION CF Phase 2a Trial Evaluating NBD1 Stabilizer, SION-719, Added to Standard of Care in Participants with Cystic Fibrosis
-
Purple Biotech Announces New Data from CAPTN-3 Platform Tri-specific IM1240
-
Armata Pharmaceuticals Announces Appointment of Biopharmaceutical Commercial Executive Daniel B. Gilmer, Ph.D. to its Board of Directors
-
Core Scientific Plans Expansion to 1.5 Gigawatts of Gross Power at Pecos, Texas Campus
-
DG Matrix Appoints Christian Belady, Originator of PUE and Former Head of Microsoft’s Data Center Business, to Executive Advisory Board and as Personal Advisor to the CEO
-
Veradermics’ Oral VDPHL01 Achieved Early, Consistent, and Robust Hair Growth in Positive Phase 2/3 ‘302’ Clinical Trial in Male Pattern Hair Loss
-
Surf Air Mobility Announces New SurfOS Modules to Reduce Fuel Costs and Optimize Crew Reserves for Airline Operations
-
SAPHNELO approved in the US for subcutaneous self-administration as a new autoinjector for the treatment of systemic lupus erythematosus
-
Cardiff Oncology to Host Key Opinion Leader Discussion on Onvansertib’s Promising Single-Agent Activity
-
Seaport Therapeutics Adds Intra-Cellular Therapies Founder and CEO, Dr. Sharon Mates, to its Board of Directors
-
Shoulder Innovations Initiates Full Commercial Launch of the InSet™ I-135RFX Humeral Stem
-
GE HealthCare management to present at upcoming investor conferences
-
tesa Selects Kinaxis as the Digital Backbone for Global Integrated Business Planning Transformation
-
From the Company That Brought You "America Reads the Bible," Great American Media Launches "America Sings the Anthem" to Honor America's 250th Birthday
-
MoonFox Alternative Data Redefines China Insights at Neudata Hong Kong Summit: A Triple-Threat of Online, Offline, and Transactional Data
-
vVARDIS Announces Investment from Apollo —Achieves Unicorn Status
-
CORSAIR Named One of Newsweek’s Most Trustworthy Companies in America 2026
-
GXO Accelerates Into U.S. Motorsports as Official Partner to Arrow McLaren
